Clinical Trial Update: 18F-Fluciclovine PET Imaging for Detecting High Grade Glioma Recurrence After Radiochemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating 18F-Fluciclovine PET imaging to detect high-grade glioma recurrence after radiochemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Grade Iii Glioma
• Grade Iv Glioma

Drugs mentioned

• 18F-Fluciclovine (fluorine-18-fluciclovine)

Snippet

Sponsor: Nicole Hill | Conditions: Grade III or Grade IV Glioma | Phase 3 | Status: UNKNOWN